Completed

Limit: 1 // Available: 0 

S. Soto (Public Health, Policy & Translational Research)

Maricopa County is committed to tackling the challenges of substance use in our community. The opioid settlement funds provide only a small part of what’s needed to address substance misuse in Maricopa County. The challenges are complex and the intent of MCDPH is to ensure that every dollar is used wisely to create the most impact. This means:

• Focus on projects that deliver immediate, measurable results and lay the groundwork for long-term change. The intent is to engage programs that meet urgent needs and address root causes of substance misuse so that the community benefits now and in the future. 

• Use strong data collection and evaluation practices to measure how well the programs work. This helps MCDPH to make informed decisions, improve our strategies, and ensure that funded programs truly make a difference. 

• Align our funding with other community resources. MCDPH will focus on areas where our money can fill gaps and support ongoing efforts, making our response as effective as possible. 

Organizations may choose to apply for one or more focus areas and may propose multiple activities under each focus area. However, each organization can only submit one application, and the total budget for all proposed activities may not exceed $500,000. 

Limit: 1 // Available: 0

M. Krunz (Electrical & Computer Engineering) 

An organization may submit one proposal per submission window. An organization must wait for a determination from NSF (e.g., Award, Decline, or Returned Without Review) on the pending proposal before submitting a new proposal in the next window. Declined proposals require a new invitation to submit (via the Concept Outline process) and significant revision, while proposals Returned Without Review may be submitted using the same invited Concept Outline (assuming that the proposal is received within one year of the original Concept Outline invitation).

The Expanding AI Innovation through Capacity Building and Partnerships (ExpandAI) program is a multi-year program that aims to significantly diversify participation in AI research, education, and workforce development through capacity development and partnerships within the National AI Research Institutes ecosystem.

PROGRAM TRACKS

This program solicitation offers two Tracks corresponding to stages of readiness for partnerships in AI Institutes. These are “ExpandAI Capacity Building Pilots” and “ExpandAI Partnerships” as described below.

Track 1: ExpandAI Capacity Building Pilots

Capacity Building Pilots (CAP) are planning and growth efforts focused on the establishment of AI activities at the funded MSI and the early exploration of future synergistic partnerships that have the potential to be part of prospective ExpandAI Partnerships. Successful pilots will result in establishing new AI research capacity, education/workforce development in AI, and/or AI infrastructure capacity at the proposing institution and, potentially, a basis for future AI partnerships. CAP activities should plan for engaging appropriate communities to test the feasibility of partnerships as well as developing plans for continuing capacity development. Plans should consider required research infrastructure, plans to leverage established groups in related research areas, and inclusion of faculty training and research experiences that emphasize the diversification of investigators.

Proposals must articulate a clear vision motivating the capacity building activities, with a focus on long-term benefits to the MSI such as enhanced faculty capacity for foundational and/or use-inspired AI research or new effective models for increased education and career pathways in AI. Proposals to this track must include a strong Institutional Need and Support Statement (see proposal preparation instructions) containing an assessment of the current AI research and instructional capacity and infrastructure, a demonstration of institutional need for capacity building in AI, and a statement of the commitment of institutional support for the proposed activities. Proposals that substantiate a strong case in this need and support statement are likely to be most compelling for the funding opportunity. Further guidance for this supporting document can be found in Proposal Preparation Instructions.

Successful proposals will feature a Capacity Building Plan that features clear and measurable outcomes/benefits of capacity building. Suitable activities for such a plan are:

• establishment or significant enhancement of foundational or use-inspired AI research, marked by increased faculty research output;
• design of academic pathways or innovative models for teaching and learning in AI, incorporating how students learn effectively in AI activities, and bringing AI disciplinary advances into the undergraduate and graduate experience;
• establishment or significant expansion of AI career pathways for students resulting from new AI activities;
• enhanced AI research infrastructure;
• significant increase in the participation of investigators and students who have been traditionally underserved and underrepresented in AI; and
• a plan for objective process evaluation in support of the proposed efforts.

Note that this list is representative of suitable activities and outcomes for this track. CAP activities need not be limited to this list, and proposals do not have to include every type of outcome represented in that list. Proposers are encouraged to select and integrate the activities most appropriate for their institutional context and their vision for capacity building toward partnerships.

Early partnership development between the proposing MSI and one or more AI Institutes is neither required nor encouraged in a CAP proposal.

Track 2: ExpandAI Partnerships

The ExpandAI Partnership (PARTNER) track is an opportunity for MSIs to scale up already-established AI research and/or education programs and to initiate/leverage new collaborations with AI Institutes. These partnerships will be multi-organization collaborations submitted by an MSI and will include a subaward to an AI Institute. PARTNER projects are centered around shared, complementary goals. Proposals will be submitted as single-organizational collaborative proposals. PARTNER proposals may only be submitted by a qualifying MSI as indicated in Eligible Institutions in this solicitation.

PARTNER proposals should scale up and make fully productive an appropriate existing capacity in AI research, education/workforce development, and/or infrastructure capacity. The proposing MSI in this track is not required to have previously been awarded a CAP project under this program. PARTNER proposals must constitute a significant new partnership that has the clear potential to build on the institution’s current AI capacity as well as leverage the intrinsic strengths and talents of the MSI for mutual benefit in collaborative AI activities.

MSIs applying for this track must demonstrate readiness to leverage external expertise and financial resources to focus on medium- and long-range plans to leverage this funding opportunity and new partnerships to develop AI capacity within the MSI, including but not limited to further development of the MSI’s envisioned methodological thrusts, use cases, educational and/or workforce development activities, and the potential for the MSI to expand and scale these efforts through formal, mutually beneficial partnerships. Proposals should include at least one (and if appropriate, more) established AI Institutes in developing a roadmap for collaborative work in some unifying theme or focus.

PARTNER proposals must feature a compelling Partnership Roadmap for collaborative work in some unifying theme or focus. Roadmaps are the beginning of a joint strategy between organizations for collaborative work. These roadmaps may also include community building activities (e.g., workshops) to further develop common interests, objectives, and goals for the growth of collaborative activities. Effective roadmaps are both depicted visually (e.g., conceptual diagram, logic model, table, etc.) and fully explained by a descriptive narrative. The roadmap should address all proposed projects involving research, education/workforce development, infrastructure, and any other types that are applicable to the collaboration. Roadmaps might address:

• enhancement of existing projects by virtue of new collaboration;
• initiation of new projects made possible by the collaboration;
• community building activities (e.g., workshops) to further develop common interests, objectives, and further growth of the partnership;
• potential and plans for scaling nascent programs;
• an evaluation plan for measuring the growth and mutual benefit of activities in all projects.

Note that this list is representative of suitable features of a Partnership Roadmap. Proposers may adapt this list and depict the roadmap in the way that best suits the unique vision of the PARTNER proposal.

Proposals to this track must include a strong Institutional Need and Support Statement from the proposing MSI (see proposal preparation instructions) containing an assessment of the current AI research and instructional capacity and infrastructure, progress in AI capacity development and how that relates to the outlook for partnership development, and a demonstration of the commitment of institutional support for the proposed activities. In addition, each proposal to this track must include an Institute Integration Plan submitted by the collaborating institute demonstrating thoughtful and well-resourced commitment to coordination mechanisms that will bring together the various participants of the project. Further guidance for these supporting documents can be found in Proposal Preparation Instructions.

Limit: 1 // Available: 0

N. Alvarez Mexia

The IDEAS grant competition assists U.S. colleges and universities in creating and/or expanding their study abroad programming in support of U.S. foreign policy goals. Building on the work achieved thus far, and the myriad opportunities that have been provided to students, microgrant proposals should seek to build additional capacity in U.S. grantee institutions. Examples may include, but are not limited to, building upon existing partnerships, reaching out to additional student groups, applying successful models to new locations, or creating toolkits for reaching underrepresented students.

Eligibility

To be eligible for consideration, proposals must meet the following criteria:

• The institution must be a current or past IDEAS grantee that has or will have concluded their award activities before September 1, 2024 and is in good standing with World Learning, with all reports and other deliverables up-to-date.
• Proposals must support projects focused primarily on U.S. undergraduate student mobility abroad, although graduate student participation in programs is allowed.
• As with the IDEAS grant, funding may not be used to support direct outbound or inbound student costs. Funds may be used to support U.S. faculty and/or staff travel overseas as well as travel for foreign faculty and/or staff to travel to the United States to support program development, resource development and dissemination, and/or research. Further details about allowable costs can be found in the Grant Competition FAQs.
• Microgrants may support the development of in-person U.S. study abroad programming in countries with a U.S. Department of State Travel Advisory Level 1, 2, or 3. Development of in-person programming in foreign locations with a U.S. Department of State Travel Advisory Level 4 is not permitted.
• Microgrants may support the development of virtual U.S. study abroad programming in all countries, regardless of their U.S. Department of State Travel Advisory level.

Note that the Primary Investigator for the microgrant application does not need to have participated personally in the previous or ongoing IDEAS grant activities; this opportunity is open to any faculty or staff person at an IDEAS grantee institution. Only ONE application per institution will be considered. Collaboration among grantee institutions is permitted and encouraged

Limit: 1 // Available: 0

S. Edmund (Nursing)

You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission. Collaboration within the institution is encouraged to ensure only one application is submitted.

This program aims to increase the supply of behavioral health professionals and improve the distribution of a well-trained behavioral health workforce. The program has a specific focus on increasing access to behavioral health services for children, adolescents, and young adults.

Limit: 5 // Available: 5

Applications such as high performance computing and lowpower electronics, both needed for artificial intelligence (AI), require leap-ahead advances in semiconductor advanced packaging. This Notice of Funding Opportunity (NOFO) seeks proposals for R&D activities that will establish and accelerate domestic semiconductor advanced packaging through investments in five (5) R&D Areas: (1) Equipment, Tools, Processes, and Process Integration; (2) Power Delivery and Thermal Management; (3) Connector Technology, including Photonics and Radio Frequency (RF); (4) Chiplets Ecosystem; and (5) Co-design/Electronic Design Automation (EDA).

The submission of a concept paper is required. Eligible applicants may submit only one concept paper per R&D Area. Each concept paper may only include one R&D Area. Applicants may submit separate concept papers on different R&D Areas.

U of A has an existing agreement with the Bureau of Humanitarian Affairs (BHA), "Humanitarian Assistance Technical Support (HATS)". As such, U of A does not intend to submit responses to ANY requests for applications from BHA technical teams. This is particularly true for Disaster Data, Assessments, and Information Management Teams. 

For additional information, please contact Corrie Hannah. 

No Applicants // Tickets: 1 // Tickets Available: 1

The Camille Dreyfus Teacher-Scholar Awards Program supports the research and teaching careers of talented early career faculty in the chemical sciences. The Award, which requires an institutional nomination, is based on an independent body of scholarship attained in the early years of their appointment, and a demonstrated commitment to education, signaling the promise of continuing outstanding contributions to both research and teaching.
 

• Eligibility:
  • From academic institutions in the States, Districts, and Territories of the United States of America that grant a bachelor’s or higher degree in the chemical sciences, including chemistry, biochemistry, materials chemistry, and chemical engineering.
  • Hold a full-time tenure-track academic appointment focused on the chemical sciences.
  • From Ph.D. granting departments in which scholarly research is a principal activity and undergraduate education is an important component.
  • Are within the first six years of their independent academic careers at the time of submission of the nomination. Experience has shown that awardees tend to be close to the end of their eligibility window, but all eligible candidates are welcome to apply.

Tickets: 1 / Available: 0

C.K. Chan

The overarching goal of this solicitation is to democratize access to NSF’s advanced cyberinfrastructure (CI) ecosystem and ensure fair and equitable access to resources, services, and expertise by strengthening how Cyberinfrastructure Professionals (CIP) function in this ecosystem. It aims to achieve this by (1) deepening the integration of CIPs into the research enterprise, and (2) fostering innovative and scalable education, training, and development of instructional materials, to address emerging needs and unresolved bottlenecks in CIP workforce development. Specifically, this solicitation seeks to nurture, grow and recognize the national CIP [1] workforce that is essential for creating, utilizing and supporting advanced CI to enable and potentially transform fundamental science and engineering (S&E) research and education and contribute to the Nation's overall economic competitiveness and security. Together, the principal investigators (PIs), technology platforms, tools, and expert CIP workforce supported by this solicitation operate as an interdependent ecosystem wherein S&E research and education thrive. This solicitation will support NSF’s advanced CI ecosystem with a scalable, agile, diverse, and sustainable network of CIPs that can ensure broad adoption of advanced CI resources and expert services including platforms, tools, methods, software, data, and networks for research communities, to catalyze major research advances, and to enhance researchers' abilities to lead the development of new CI. 

Limit: 1 / Tickets Available: 0

D. Bhattacharya 

NIH recognizes that modern physical infrastructure is necessary for the conduct of cutting-edge research or support specialized breeding operation. Dedicated space is required to house specialized equipment and to carry out experimental protocols. Equipment that enables automation and husbandry of the breeding facility, enhances modern operation, allows telemetry for field/corral monitoring, facilitates social behavioral interactions may be eligible under this NOFO. The scope of individual applications will vary and depend on the currently available infrastructure at the applicant institution, as well as the present and anticipated HIV/AIDS research needs. Requests must be justified by the needs for expanding the breeding capacity for support of HIV/AIDS research. The project, when completed, is expected to provide significant long-term cost-effective support for HIV/AIDS research, bringing the capacities and capabilities to a new level. Consequently, the applicant institution should demonstrate future-looking commitments towards the facility and HIV/AIDS research therein, by attaching a letter of support from a high-ranking institutional official.

Limit: 1 // Available: 0

R. Shroff (Medicine)

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

The NCI National Clinical Trials Network (NCTN) was established for the conduct of large-scale, national, oncology treatment and advanced imaging clinical trials in an era of precision medicine.

Recent advances in deciphering the cancer genome, along with the emergence of successful targeted agents, immunotherapies, and cellular therapies, have fundamentally changed our approach to cancer treatment and have introduced new challenges to performing clinical trials. Due to the low incidence of certain molecular abnormalities, the development of targeted therapies often requires an infrastructure for the conduct of clinical trials that can screen large numbers of patients with the same or different cancer type to identify those patients whose tumors contain the distinct molecular targets of the therapies being tested. Immunotherapeutic approaches also present a similar challenge in that not all tumor types respond to this approach, and selecting the cancer types most likely to respond is critical for success.

The NCTN's integrated and collaborative network infrastructure has allowed the Program to meet the challenges of evaluating emerging therapies within its broad investigator base drawn from NCI-designated Cancer Centers, the NCI Community Oncology Research Program (NCORP), Minority/Underserved NCORPs, and other academic and community hospitals and private practitioners across the U.S. and internationally. The primary focus of the NCTN is the conduct of multi-center, late-phase, clinical treatment trials (i.e., randomized phase 2 and phase 3 trials) and investigation of new advanced imaging techniques; however, appropriate preliminary studies needed for development of potential definitive trials, especially umbrella/basket trials and rare tumor trials oriented to discovery, are also conducted when an extensive, national patient catchment area is required. With its state-of-the-art clinical trials infrastructure, the NCTN can implement and completes trials rapidly. The NCTN has streamlined trial registration, data management, and tumor banking processes. It has a Cancer Trials Support Unit (CTSU) to provide online access to all necessary study materials and a Central Institutional Review Board (CIRB) to make ethics review easier and less redundant across the country. The NCTN also has appeal for industry partners such as biotechnology and pharmaceutical companies that collaborate on NCTN trials, including precision medicine trials harnessing next generation DNA and RNA sequencing methods to inform treatment choices. NCTN's resources are ideal for screening large numbers of patients to identify patients whose tumors exhibit the molecular features that may be responsive to new, targeted treatments and/or immunotherapy approaches. In addition, biospecimens collected from patients on NCTN trials are available to help determine the underlying biological reasons for response and resistance to therapy.

The NCTN also promotes the evaluation of multi-modality treatments, including surgery and radiotherapy in combination with novel agents, and has a commitment to the conduct of trials in special populations (e.g., children, adolescents, young adults, and underserved populations) as well as in rare tumor types. This focus allows the NCTN Program to complement, rather than duplicate, research conducted by the private sector. Annual accrual to NCTN trials has remained in the 17,500 to 22,000 patient range in mostly large phase 2 and phase 3 trials, but with a larger number of patients screened on study to determine whether they might benefit from the therapy under evaluation.

Each of the key components of the NCTN Program is described briefly below.

• Network Group Operations Centers: The Operations Centers provide scientific leadership for developing and implementing multi-disciplinary, multi-institutional trials in a range of diseases and special populations with specific scientific strategy and goals. The Operations Centers' scientific goals may include strategic innovation in advanced technology for specific research areas (e.g., advanced imaging methods/agents, radiotherapy) and the testing of innovative concepts and tools in prospective, multi-institutional clinical trials. Operations Centers are responsible for trial operations including timely protocol development and management, compliance with the Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) regulatory and patient protection requirements, audits, training, quality assurance, and site support. The Operations Centers are expected to be closely integrated with their corresponding Statistics and Data Management Center in all aspects of trial operations through jointly developed policies and procedures for clinical trial development and conduct. The Operations Centers are also responsible for Network Group administration, including financial management, monitoring of member institution/site performance, coordination of biospecimen collection from patients on clinical trials, and adherence to all applicable NIH/NCI policies and regulations. Network Group Operations Centers may also provide trial operations for NCI Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (NCI/DCTD, approved, multi-center phase 2 and phase 3 trials originating outside the Network Groups in special situations.
• Network Group Statistics and Data Management Centers: These Centers are responsible for providing the statistical expertise required to ensure effective scientific design and conduct of clinical trials as well as leadership in innovation in statistical methodology. These Centers are also responsible for data management, data analysis, and statistical analysis for NCTN trials led by their affiliated Network Group Operations Center as well as for translational and other ancillary studies associated with the trials.
• Network Group Integrated Translational Science Centers - These awards provide support for leadership and expertise to facilitate incorporating translational science into Network Group clinical trials.
• Network Lead Academic Participating Sites: These academic institutions/sites provide scientific leadership in development and conduct of clinical trials in association with one or more adult U.S. Network Groups as well as substantial accrual to clinical trials conducted across the entire NCTN.
• Network Radiotherapy and Imaging Core Services Center: This institution/organization provides scientific and technical expertise for incorporation of appropriate, integrated quality assurance/control and image data management for applicable clinical trials conducted by the NCTN that require specialized quality assurance/control or imaging data management and/or assessment for radiotherapy and imaging interventions. In addition, the Center may also provide similar services for other approved NCI-supported clinical trials network programs (e.g., NCI/DCTD/CTEP early phase clinical trial network program and the NCI Division of Cancer Prevention (NCI/DCP) NCI Community Oncology Research Program (NCORP).
• Canadian Collaborating Clinical Trials Network: This Canadian organization is a non-profit clinical trials organization capable of being a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials that have relevance for U.S. cancer patient populations. Incorporation of a Canadian Clinical Trials Network as a collaborating partner brings an additional advantage as U.S. Network Groups are anticipated to have Canadian member sites. A Canadian network can help reduce duplicative regulatory staff at U.S. NCTN Group Operations Centers.

Interactions with Other NCI-supported Programs. In addition to the six key components of the NCTN that are described above that are directly funded by the NCTN Program, other NCI grant and contract-supported Programs and their awardees as well as NCI Advisory Committees have important supporting roles in carrying out the research objectives of the NCTN Program. Thus, the NCTN awardees are expected to interact as appropriate with such entities/programs as the NCI Clinical Trials Tumor Banks, the NCI Community Oncology Research Program (NCORP) and Minority/Underserved NCORPs, the NCI Cancer Trials Support Unit, the pediatric and adult NCI Central Institutional Review Boards, and NCI Advisory and Scientific Committees, including the NCI Scientific Steering Committees.

Main Research Objectives and Requirements of this NOFO

The Network Lead Academic Participating Site application must address the following 2 required functional components related to clinical treatment trials and advanced imaging trials for adult cancer patients only:

Clinical Trial Program - This functional component encompasses the LAPS scientific leadership in helping to develop and conduct clinical trials in association with one or more Network Groups, including the LAPS support of NCTN initiatives and mentorship of junior investigators.

Site Accrual Program This functional component provides robust accrual to NCTN trials across the Network, including accrual to rare cancers and accrual from special populations (e.g., minority and underserved communities, adolescents and young adults), as well as timely activation of trials and good clinical trial stewardship.